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Abstract
Background: The characterization of malaria parasite populations circulating in an area is part of site
characterization, as a basis for evaluating the impact of malaria interventions on genetic diversity, parasite species,
and multiplicity of infection. The present study was aimed at analysing genetic diversity of Plasmodium falciparum
merozoite surface proteins 1 and 2 (MSP-1 and MSP-2) and to determine the multiplicity of infection in clinical
isolates collected from children living in the Southern district of Brazzaville in the Republic of Congo.
Methods: A total of 125 isolates from patients with uncomplicated malaria attending Terinkyo and Madibou health
centres were collected between January and June 2005 while evaluating the therapeutic efficacy of amodiaquine-
artesunate combination. DNA was extracted and msp-1 and msp-2 genes were genotyped using allele-specific
nested-PCR.
Results: Out of 468 distinct fragments detected, 15 msp-1 and 20 msp-2 genotypes were identified. For the msp-1
gene, K1 family was the predominant allelic type carried alone or in association with RO33 and Mad20 types,
whereas the 3D7 family was the most prevalent in the msp-2 gene. Overall, the mean multiplicity of infection was
2.2. Out of 125 samples, 104 (83%) harboured more than one parasite genotype. There was no statistical significant
difference in the multiplicity of infection by either sex or age of patients. However, a statistically significant
correlation was found between parasite densities and the number of genotypes.
Conclusion: Polymorphism in P. falciparum clinical isolates from Brazzaville was high and mainly of multiple clones.
The basis for the positive association between parasite densities and multiplicity of infection is discussed.
Background
Malaria, a disease mostly caused by Plasmodium falci-
parum, is a major public health problem. The global bur-
den is estimated at 225 million malaria cases every year
resulting into 781,000 deaths [1], sub-Saharan Africa being
the most affected region. In the Republic of Congo, like in
many other sub-Saharan African endemic countries,
malaria vulnerable groups are children and pregnant
women [2].
Data collected from 2000 to 2003 by the University
Teaching Hospital of Brazzaville during studies on chloro-
quine resistance showed that 22% of children deaths at
pediatric health facilities were due to malaria [3]. Recent
studies on anti-malarial drug resistance in Brazzaville have
confirmed high level chloroquine resistance and the ineffi-
cacy of sulphadoxine-pyrimethamine and amodiaquine
either singly or in combination for the treatment of
uncomplicated malaria [4-6]. Consequently, in February
2006, the Republic of Congo changed its anti-malarial
drug policy for treating uncomplicated malaria to artesu-
nate-amodiaquine combination, as the first-line drug, and
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recommendation of the World Health Organization.
Despite policy change, there is still need to collect more
data on the epidemiology of malaria in the country to
facilitate the development and implementation of other
malaria control interventions such as the search for alter-
native drugs, vaccine trials and indoor residual spraying.
In this regards, characterization of malaria parasite popu-
lations circulating in an area is part of site characteriza-
tion before any intervention, as a basis for evaluating the
impact of the intervention on genetic diversity, parasite
species, and multiplicity of infection (MOI) in the human
or vector host. One of the limitations to the development
of an effective malaria vaccine against P. falciparum is
the extensive genetic diversity in parasite populations lim-
iting the efficacy of acquired protective immunity to
malaria [7]. MOI and demonstration of presence of para-
site in blood are among the most useful indicators of
clinical disease [8-11]. In the human host, MOI is defined
as the mean number of detected P. falciparum genotypes
per infected individual.
Asexual blood stages antigens, such as merozoite sur-
face protein-1 (MSP-1) and merozoite surface protein-2
(MSP-2) are considered prime candidates for the develop-
ment of malaria vaccine and are also suitable markers for
the identification of genetically distinct P. falciparum
parasite sub-populations [12]. Polymorphism in msp-1
and msp-2 has been reported in several parts of world
including in Central Africa [13-15]. However, there is
limited data on the genetic diversity among P. falciparum
populations from the Republic of Congo.
Molecular studies to identify P. falciparum genes
mutations associated with anti-malarial drugs resistance,
such as those found in P. falciparum chloroquine resis-
tance transporter, dihydrofolatereductase, dihydroptero-
ate synthase have been conducted in the Republic of
Congo since 2003, before introducing artemisinin-based
combination treatment (ACT) in 2006 [5,16,17]. Base on
the literature, only one publication has reported the
genetic diversity of P. falciparum infections and MOI in
a group of children with uncomplicated malaria in Braz-
zaville [5]. Following massive deployment of insecticide
treated nets and free treatment with ACT for malaria in
the country, it is important to evaluate the genetic pro-
file of malaria strains before and during these effective
interventions.
The present characterized allelic polymorphism of
msp-1 and msp-2 and determined the multiplicity of
infection in clinical P. falciparum isolates collected from
children living in the southern district of Brazzaville, the
capital of the Republic of Congo. The Ministry of Public
Health of the Republic of Congo approved the study
ethically and scientifically.
Methods
Study area
The study materials were collected from patients attend-
ing Centre de Santé Intégré (CSI) in Terinkyo and Madi-
bou hospitals, located in the southern part of Brazzaville.
This urban area has stable and highly endemic malaria
with perennial transmission [18] with an entomological
inoculation rate (EIR) of 22.5 infective bites/person/year
was reported [19]. Malaria infection is primarily due to
P. falciparum.
Study population and blood samples collection
A total of 125 P. falciparum infected blood used in this
study were collected from children and adults presenting
to the two health centres and enrolled into the study for
evaluating the therapeutic efficacy of artesunate-amodia-
quine combination (Dr. Ndounga, unpublished data)
from February to June 2005. The inclusion criteria of
participants were: auxiliary temperature ≥ 37.5°C mea-
sured with an electronic thermometer, malaria parasite
(P. falciparum)i nt h et h i c kb l o o ds m e a r s( ≥ 800 para-
sites/μL), no symptoms of severe malaria or febrile condi-
tions caused by other diseases. Informed consent was
obtained from adult patients and from parents/guardians
for the children. Additionally, at inclusion into the study
and before treatment, three drops of blood from each
patient were blotted on to 3 MM Whatman filter paper,
dried and stored in individual sealed envelopes until used
for DNA extraction.
Extraction of parasite DNA
Genomic DNA was extracted from blood samples
collected on filter paper using QiaAmp DNA mini kit
(Qiagen, Hilden, Germany) according to the manufac-
turer’s instruction. Then, the DNA was recovered in
100 μl of elution buffer from the kit. All parasites DNA
e x t r a c t e dw e r es t o r e da t-2 0 ° Cu n t i lu s e .
Allelic typing of P. falciparum msp-1 and msp-2 genes
All samples were genotyped for P. falciparum using the
nested polymerase chain reactions (PCRs) technique. The
highly polymorphic loci, msp-1 block 2 and msp-2 central
region were used as markers for this genotyping as
described previously [11-13]. The initial amplifications
were followed by individual nested PCR reactions using
specific primers for K1, MAD20, and RO33 allelic families
of msp-1, and for FC27 and 3D7 allelic families of msp-2.
Allelic specific positive controls and DNA free negative
controls were included in each set of reaction. Five micro-
liters of each of the PCR products were loaded on 2%
agarose gel, stained with the Syber Green, separated by
electrophoresis and visualized under UV trans-illumina-
tion. Individual alleles were identified by fragment length
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the size of the PCR products were estimated using a 100
bp DNA ladder marker (Invitrogen, Karlsruhe, Germany).
The size polymorphism in each allelic family was analysed;
assuming that one band represented one amplified PCR
fragment derived from a single copy of P. falciparum msp-
1 or msp-2 genes. Alleles in each family were considered
the same if fragment size were within 20 bp interval. The
minimum number of genotypes per isolate was estimated
to be the highest number of fragments identified for either
msp-1 or msp-2.
Malaria species genotyping
To confirm that all study participants were infected with
only P. falciparum, all samples were subjected to Plasmo-
dium species genotyping as described elsewhere [20]. At
the second PCR round, only Plasmodium malariae and
Plasmodium ovale species were investigated; P. falciparum
being already done by msp-1 and msp-2 genotyping. The
PCR products were loaded on 2% agarose gels and visua-
lized under UV trans-illumination. The DNA positive con-
trols for P. malariae and P. ovale as well as DNA free
negative controls were included in each set of reaction.
Data and statistical analysis
The msp-1 and msp-2 allele frequency was calculated as the
proportion of allele found for the allelic family out of the
alleles detected in isolates. The multiplicity of infection was
defined as the minimum number of P. falciparum geno-
types per infected subject and estimated by dividing the
number of amplified PCR fragments reflecting parasite gen-
otypes by the number of positive samples. The chi-square
test was used to compare proportions. Spearman’sr a n k
correlation coefficients were calculated to assess association
between MOI and geometric mean parasite densities and
age. Statistical significance was defined as P values < 0.05.
Results
Characteristics of patients and parasitaemia
A total of 125 patients with clinical symptoms of malaria
and microscopically confirmed P. falciparum infection
were enrolled in the study. Sixty-seven and 48 were chil-
dren aged between seven months to five years of age, and
between six to 15 years of age, respectively; ten patients
were more than 16 years old. Sixty-eight patients were
males and 57 were females.
The geometric mean parasite density was 62,170 para-
sites/μl of blood with the range of 830-914,000 parasites/
μl (Table 1).
Plasmodium species
Isolates from 125 patients were PCR-typed for speciation
and all were confirmed to contain P. falciparum. Of these,
two isolates were mixed infections of P. falciparum/
P. malariae and P. falciparum/P. ovale.
Allelic polymorphism of P. falciparum (msp-1 and msp-2)
The parasite DNA from all 125 P. falciparum isolates
were analysed for msp-1 and msp-2 genes, whereby only
one isolate did not amplify for msp-1 gene. The efficiency
of msp-1 and msp-2 genes amplification reactions with
family-specific primers was 100% and 95%, respectively.
A total of 468 distinct fragments were detected, out of
which, 15 msp-1 and 20 msp-2 different alleles were iden-
tified. Within the msp-1 gene (Figure 1), eight and six
alleles belonged to K1 (48% of overall detected msp-1
alleles) and Mad20 (29%) families, respectively. The
RO33 (23%) family did not show any polymorphism, with
only one variant (180 bp) detected. The K1 family was
the predominant allelic type carried alone (23.4%) or in
mixed infection with RO33 (17%) and Mad20 (20%) types
as well as when the tree types are observed in the same
isolates (Table 2).
The msp-2 gene yielded 10 alleles for each family
(Figure 2). The 3D7 family was more prevalent with
57% of overall detected msp-2 alleles compared to 38%
of FC27. Forty-four (35.5%) of the isolates carried both
msp-2 allelic types. Ten genotypes (5%) could not be
assigned to any family.
Table 1 Characteristics of individuals with uncomplicated
P.falciparum malaria from Brazzaville, Republic of Congo
Characteristics of patients No. Values
No. of Male/Female 125 68/57
Mean age (years) 125 8 (0.7-54)
Mean parasite density (parasites/μl) 125 62,170 (830-914,000)
Multiplicity of P. falciparum infection 125 2.2
Polyclonal infections (%) 104 83
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Figure 1 Prevalence of P. falciparum msp-1 alleles in
Congolese clinical isolates. Alleles of the msp-1 gene were
classified by fragment length (in base pairs) resulting from PCR
amplifications with allele specific primers.
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densities, age and gender
Overall, the mean multiplicity of infection was 2.2. Of 125
samples, 104 (83%) harboured more than one parasite gen-
otype. When considering msp-1 and msp-2 genes sepa-
rately, the overall multiplicity of infection was 2 and 1.7
respectively, while eighty-nine (72%) and 67 (54%) of iso-
lates carried more than one parasite genotype respectively.
As presented on the Tables 2 and 3 the type of combination
of multiple msp-1 or msp-2 alleles did not show any impact
on the parasite density. Moreover, no statistical significant
difference was observed in the multiplicity of infection and
parasite density according to the age (Figure 3) and gender.
However, a significant correlation was observed between
mean parasite densities and the number of alleles (Spear-
man rank coefficient for msp-1 = 0.1784; p = 0.0474, and
Spearman rank coefficient for msp-2 = 0.1834; p = 0.0406).
The correlation was higher when msp-1 and msp-2 alleles
are taken together (Spearman rank coefficient = 0.2508; p =
0.0048), since the number of genotypes per isolate was cal-
culated as the highest number of fragments for either msp-
1 or msp-2 (Figure 4).
Discussion
The level of antigenic diversity of P. falciparum popula-
tions in an area is likely to affect acquisition of immu-
nity to malaria [21]. Therefore, the understanding of the
genetic structure of parasite population is necessary for
planning of malaria control interventions.
Allelic specific P. falciparum msp-1 and msp-2 geno-
typing has shown that malaria parasite population in
Brazzaville is highly diverse. However, the number of
alleles may have been underestimated due to the limit
of the technique. Indeed, fragments within the length
interval of less than 20 bp could not clearly be distin-
guished. Thus, a minimum of fifteen alleles of msp-1
were observed, in which, K1 allelic family was predomi-
nant, consistent with the previous study in the same
locality and others studies in the central Africa sub-
region [5,13,22,23]. Although Mad20 family was diverse,
the distribution of Mad20 alleles was almost equal to
single detected RO33 allele. Regarding the msp-2 locus,
alleles belonging to 3D7 family were mostly detected,
both in mono-infection and mixed infection with FC27
alleles. This finding differs from those of the previous
study [5], where RO33 and K1 families were similarly
distributed, and FC27 alleles more predominant. The
difference may either be due to a small sample size in
the first study or the existence of a true difference in
the two study areas. Despite the fact that both studies
Table 2 Distribution of msp1 and msp2 detected allelic
families and corresponding mean parasite densities in
Congolese P.falciparum isolates
Mean Parasite Densities
MSP1 MSP2
FC27 3D7 FC27+3D7
K1 65273 58899 59110
Mad20 89818 76886 75476
RO33 60116 57269 61454
K1+Mad20 73789 63524 61976
RO33+K1 62561 55788 57151
RO33+Mad20 82289 70746 70738
RO33+K1+Mad20 73789 64104 62465
In bold are presented multiclonal infections.
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Figure 2 Prevalence of different P. falciparum msp-2 alleles in
Congolese clinical isolates.
Table 3 Profile of multiple infections according to the
parasite densities (P.falciparum parasites/μl of blood)
Multiplicity of Infection Mean Parasite Densities
1 30,490
2 64,979
3 70,216
4 90,632
5 45,390
Total 62,170
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Figure 3 Relation between multiplicity of P. falciparum
infection as well as mean geometric density with age.
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population for the first study conducted in 2003 lived in
rural Southern areas, just after the armed conflicts in
the Republic of Congo. Therefore, malaria parasite pro-
files found in this investigation may have not reflected
the true parasite picture compared to the current study.
Repeated studies are required to characterize and con-
firm the real genetic diversity of parasite populations in
this area. Limited polymorphism in RO33 family is simi-
lar to findings in Senegal [24], Brazil [25] and in Iran
[26]. Three and 4 RO33 alleles were found in Gabon
[23] and Uganda [27] respectively. The current parasite
profile with the predominance of K1 and 3D7 was also
observed in isolates from patients with uncomplicated P.
falciparum malaria in Gabon [22,23].
Multiple genotypes of P. falciparum infections were
detected in 83% of Congolese isolates with an overall
mean multiplicity of infection of 2.2 (with 2 and 1.7 in
msp-1 and msp-2 respectively). This corroborates reports
from other areas of Central Africa with intense malaria
transmission [22,28]. In this study, the number of para-
site genotypes carried by subjects with symptomatic
infections was not influenced by age as shown elsewhere
[29]. Irrespective of age, the sensitivity of the technique
may not allow for the detection of minor genotypes when
the parasite density of disease-inducing strain is high.
However, in contrast with the first report in Brazzaville
[5], P. falciparum infection in this symptomatic population
shows a significant correlation between parasite density
and the number of parasite genotype. This suggests that
symptomatic P. falciparum infection in this population is
associated with the presence and growth of recently inocu-
lated parasite strain(s) to which individuals have either not
previously been exposed to or have not fully developed
immunity [13,30]. This observation in Congolese popula-
tion is in agreement with the study conducted in Bangui
[29] and in Mozambique [31]. The msp-1 and msp-2
genes appeared polymorphic, and both taken together, the
relation between parasite density and multiplicity of infec-
tion become more pronounced. This finding supposed
that in area with high transmission where individuals are
exposed to several different clones, disease-inducing
strains may have similar growing capacity leading to the
increase of their parasite densities. Consequently, with the
technique used, the high density may increase the prob-
ability to distinguish more clones in the complex
infections.
Despite the lack of recent entomological data from
Brazzaville, the latest estimation being in 1985 [18], the
genetic diversity and multiplicity of infection found in
the present study confirm intense malaria transmission
in the area. Most likely, fluctuations in alleles were
related to variations of the allele ratios in peripheral
blood, as observed over several months in the absence
of malaria transmission [32]. In this study, blood sam-
ples were collected during the rainy season of January to
June, when malaria transmission is very intense. All year
round studies covering dry and rainy seasons are needed
to get the real picture of genetic profiles in this area
including a sense on seasonal variations.
With regard to malaria speciation, two isolates had
mixed infections of P. falciparum + P. malariae and P.
falciparum + P. ovale, confirming high sensitivity of
molecular tools in detecting sub-microscopic infection.
Conclusion
The description of malaria parasite population remains a
priority malaria research area in the Republic of Congo
for a better understanding and evaluation of on-going
malaria control interventions. This study was conducted
before the implementation of the new policy for the
treatment of uncomplicated malaria using ACT. Assess-
ment of the impact of ACT on malaria parasite popula-
tion and characterization of mutations in P. falciparum
genes associated with anti-malarial drug resistance would
be useful developments.
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